Syschem (India) Limited (BOM:531173)

Market Cap	2.58B +48.2%
Revenue (ttm)	5.45B +62.5%
Net Income	82.03M
EPS	1.47
Shares Out	49.01M
PE Ratio	35.79
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,313
Average Volume	22,296
Open	48.00
Previous Close	49.38
Day's Range	48.00 - 51.80
52-Week Range	36.11 - 62.00
Beta	-0.67
RSI	67.51
Earnings Date	May 7, 2026

About Syschem (India)

Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and ...

• Industry: Industrial Organic Chemicals
• Founded: 1993
• Employees: 115
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531173

Financial Performance

In fiscal year 2025, Syschem (India)'s revenue was 3.86 billion, an increase of 65.43% compared to the previous year's 2.33 billion. Earnings were 4.60 million, a decrease of -83.34%.